Ngā hua rapu kaituhi

1

Soluble markers of allergic inflammation mā Per Venge

I whakaputaina 1994

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Monitoring the allergic inflammation mā Per Venge

I whakaputaina 2003

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

The Role of The Human Neutrophil in the Inflammatory Reaction mā Inge Olsson, Per Venge

I whakaputaina 1980

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Cationic Proteins of Human Granulocytes. II. Separation of the Cationic Proteins of the Granules of Leukemic Myeloid Cells mā Inge Olsson, Per Venge

I whakaputaina 1974

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Cationic Proteins of Human Granulocytes mā Per Venge, Inge Olsson

I whakaputaina 1975

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients mā S. Rak, O. Löwhagen, Per Venge

I whakaputaina 1988

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Troponin T Identifies Patients With Unstable Coronary Artery Disease Who Benefit From Long-Term Antithrombotic Protection mā Bertil Lindahl, Per Venge, Lars Wallentin

I whakaputaina 1997

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Eosinophils in exercise-induced asthma mā Per Venge, Jörn Henriksen, Ronald Dahl

I whakaputaina 1991

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men mā Björn Zethelius, Nina Johnston, Per Venge

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. mā Lena Håkansson, Roger Hällgren, Per Venge

I whakaputaina 1980

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Biopsy markers of airway inflammation and remodelling mā Peter K. Jeffery, A. Laitinen, Per Venge

I whakaputaina 2000

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
12

Human eosinophil peroxidase: purification and characterization. mā M. G. Carlson, C G Peterson, Per Venge

I whakaputaina 1985

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Clinical Performance of Two Highly Sensitive Cardiac Troponin I Assays mā Per Venge, Stefan James, Leif Jansson, Bertil Lindahl

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Cytokine‐regulated accumulation of eosinophils in inflammatory disease mā Maria Lampinen, Marie Carlson, Lena Håkansson, Per Venge

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
15

N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation mā Tomas Jernberg, Mats Stridsberg, Per Venge, Bertil Lindahl

I whakaputaina 2002

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Factors Influencing the 99th Percentile of Cardiac Troponin I Evaluated in Community-Dwelling Individuals at 70 and 75 Years of Age mā Kai M. Eggers, Lars Lind, Per Venge, Bertil Lindahl

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung mā Jonas Venge, Maria Lampinen, Lena Håkansson, S. Rak, Per Venge

I whakaputaina 1996

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure mā S. Rak, Anette Björnson, Lena Håkanson, Sverre Sörenson, Per Venge

I whakaputaina 1991

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly Population mā Kai M. Eggers, Per Venge, Bertil Lindahl, Lars Lind

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

The Antibody Configurations of Cardiac Troponin I Assays May Determine Their Clinical Performance mā Stefan James, Mats Flodin, Nina Johnston, Bertil Lindahl, Per Venge

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Per Venge

Soluble markers of allergic inflammation mā Per Venge

Monitoring the allergic inflammation mā Per Venge

The Role of The Human Neutrophil in the Inflammatory Reaction mā Inge Olsson, Per Venge

Cationic Proteins of Human Granulocytes. II. Separation of the Cationic Proteins of the Granules of Leukemic Myeloid Cells mā Inge Olsson, Per Venge

Cationic Proteins of Human Granulocytes mā Per Venge, Inge Olsson

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients mā S. Rak, O. Löwhagen, Per Venge

Troponin T Identifies Patients With Unstable Coronary Artery Disease Who Benefit From Long-Term Antithrombotic Protection mā Bertil Lindahl, Per Venge, Lars Wallentin

Eosinophils in exercise-induced asthma mā Per Venge, Jörn Henriksen, Ronald Dahl

Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men mā Björn Zethelius, Nina Johnston, Per Venge

Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. mā Lena Håkansson, Roger Hällgren, Per Venge

Biopsy markers of airway inflammation and remodelling mā Peter K. Jeffery, A. Laitinen, Per Venge

Human eosinophil peroxidase: purification and characterization. mā M. G. Carlson, C G Peterson, Per Venge

Clinical Performance of Two Highly Sensitive Cardiac Troponin I Assays mā Per Venge, Stefan James, Leif Jansson, Bertil Lindahl

Cytokine‐regulated accumulation of eosinophils in inflammatory disease mā Maria Lampinen, Marie Carlson, Lena Håkansson, Per Venge

N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation mā Tomas Jernberg, Mats Stridsberg, Per Venge, Bertil Lindahl

Factors Influencing the 99th Percentile of Cardiac Troponin I Evaluated in Community-Dwelling Individuals at 70 and 75 Years of Age mā Kai M. Eggers, Lars Lind, Per Venge, Bertil Lindahl

Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung mā Jonas Venge, Maria Lampinen, Lena Håkansson, S. Rak, Per Venge

The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure mā S. Rak, Anette Björnson, Lena Håkanson, Sverre Sörenson, Per Venge

Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly Population mā Kai M. Eggers, Per Venge, Bertil Lindahl, Lars Lind

The Antibody Configurations of Cardiac Troponin I Assays May Determine Their Clinical Performance mā Stefan James, Mats Flodin, Nina Johnston, Bertil Lindahl, Per Venge

Ngā utauta rapu:

Ngā marau whai pānga